JPWO2020203998A1 - - Google Patents

Info

Publication number
JPWO2020203998A1
JPWO2020203998A1 JP2021512133A JP2021512133A JPWO2020203998A1 JP WO2020203998 A1 JPWO2020203998 A1 JP WO2020203998A1 JP 2021512133 A JP2021512133 A JP 2021512133A JP 2021512133 A JP2021512133 A JP 2021512133A JP WO2020203998 A1 JPWO2020203998 A1 JP WO2020203998A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512133A
Other languages
Japanese (ja)
Other versions
JP7250907B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020203998A1 publication Critical patent/JPWO2020203998A1/ja
Priority to JP2023045195A priority Critical patent/JP7684343B2/ja
Application granted granted Critical
Publication of JP7250907B2 publication Critical patent/JP7250907B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/20Esters of polyhydric alcohols or polyhydric phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5138Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10Esters
    • C08F120/20Esters of polyhydric alcohols or polyhydric phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F126/00Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F126/06Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C08F126/08N-Vinyl-pyrrolidine
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04Homopolymers or copolymers of esters
    • C08L33/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP2021512133A 2019-03-29 2020-03-30 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤 Active JP7250907B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023045195A JP7684343B2 (ja) 2019-03-29 2023-03-22 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019067826 2019-03-29
JP2019067826 2019-03-29
PCT/JP2020/014668 WO2020203998A1 (ja) 2019-03-29 2020-03-30 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023045195A Division JP7684343B2 (ja) 2019-03-29 2023-03-22 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤

Publications (2)

Publication Number Publication Date
JPWO2020203998A1 true JPWO2020203998A1 (https=) 2020-10-08
JP7250907B2 JP7250907B2 (ja) 2023-04-03

Family

ID=72668997

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021512133A Active JP7250907B2 (ja) 2019-03-29 2020-03-30 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤
JP2023045195A Active JP7684343B2 (ja) 2019-03-29 2023-03-22 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023045195A Active JP7684343B2 (ja) 2019-03-29 2023-03-22 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤

Country Status (6)

Country Link
US (1) US12297302B2 (https=)
EP (1) EP3950735A4 (https=)
JP (2) JP7250907B2 (https=)
CN (3) CN116606393A (https=)
CA (1) CA3134852A1 (https=)
WO (1) WO2020203998A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022161408A (ja) * 2021-04-09 2022-10-21 株式会社日本触媒 血液または血小板保存容器
JP7778816B2 (ja) * 2021-12-15 2025-12-02 株式会社日本触媒 コンジュゲート化合物およびコンジュゲート化合物の製造方法
WO2025022920A1 (ja) * 2023-07-26 2025-01-30 株式会社日本触媒 脂質ナノ粒子

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10506127A (ja) * 1995-07-10 1998-06-16 ヘレウス・クルツァ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 芳香族カルボン酸無水物とヒドロキシ(メタ)アクリレートからなる芳香族カルボン酸誘導体、並びにこれらの化合物を含有する配合物
JP2003508125A (ja) * 1999-09-02 2003-03-04 アルコン,インコーポレイテッド 移植片用の共有結合した親水性塗装組成物
WO2008084656A1 (ja) * 2006-12-22 2008-07-17 Sekisui Chemical Co., Ltd. ガラスペースト
JP2010531166A (ja) * 2007-06-22 2010-09-24 ボーシュ アンド ローム インコーポレイティド 眼科用溶液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
US4529786A (en) * 1981-03-30 1985-07-16 Celanese Corporation Acrylate and methacrylate monoesters of pentaerythritol and pentaerythritol orthoesters and polymers and copolymers derived therefrom
US4855369A (en) * 1985-12-11 1989-08-08 Exxon Chemical Patents Inc. High solids acrylic-based coatings
US6632905B2 (en) 1999-09-02 2003-10-14 Alcon Universal Ltd. Covalently-bound, hydrophilic coating compositions for surgical implants
AU2002353485B2 (en) * 2001-12-04 2009-01-15 Ben Gurion University Of The Negev Research And Development Authority Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
US20080019918A1 (en) * 2004-09-10 2008-01-24 Takao Aoki Medicinal Preparation
EP2128180A1 (en) * 2008-05-29 2009-12-02 Unilever N.V. Amphiphilic branched polymers and their use as emulsifiers
GB201003970D0 (en) * 2010-03-10 2010-04-21 Univ Sheffield Polymer synthesis
JP5854998B2 (ja) * 2010-07-24 2016-02-09 株式会社日本触媒 親水化処理剤
JP5538315B2 (ja) 2011-07-20 2014-07-02 桜宮化学株式会社 エマルジョン燃料
JP6887713B2 (ja) * 2016-06-16 2021-06-16 エルジー・ケム・リミテッド 両親媒性高分子
US20190218323A1 (en) * 2016-08-08 2019-07-18 The University Of Liverpool Branched polymers
JP7076971B2 (ja) 2017-09-28 2022-05-30 キヤノン株式会社 撮像装置およびその製造方法ならびに機器

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10506127A (ja) * 1995-07-10 1998-06-16 ヘレウス・クルツァ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 芳香族カルボン酸無水物とヒドロキシ(メタ)アクリレートからなる芳香族カルボン酸誘導体、並びにこれらの化合物を含有する配合物
JP2003508125A (ja) * 1999-09-02 2003-03-04 アルコン,インコーポレイテッド 移植片用の共有結合した親水性塗装組成物
WO2008084656A1 (ja) * 2006-12-22 2008-07-17 Sekisui Chemical Co., Ltd. ガラスペースト
JP2010531166A (ja) * 2007-06-22 2010-09-24 ボーシュ アンド ローム インコーポレイティド 眼科用溶液

Also Published As

Publication number Publication date
JP7684343B2 (ja) 2025-05-27
CA3134852A1 (en) 2020-10-08
EP3950735A4 (en) 2023-01-04
JP7250907B2 (ja) 2023-04-03
US12297302B2 (en) 2025-05-13
CN113646341A (zh) 2021-11-12
CN116606393A (zh) 2023-08-18
US20220185918A1 (en) 2022-06-16
WO2020203998A1 (ja) 2020-10-08
CN116589702A (zh) 2023-08-15
JP2023076520A (ja) 2023-06-01
EP3950735A1 (en) 2022-02-09
CN113646341B (zh) 2023-04-18

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220802

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230322

R150 Certificate of patent or registration of utility model

Ref document number: 7250907

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150